Person Details

Susan Vogt

Susan Vogt, Independent Director

Susan Vogt has more than thirty-five years' experience in the global life science research, pharmaceutical, biotech and clinical diagnostics markets, most recently as the Chief Executive Officer of venture-backed Aushon BioSystems, a life science and diagnostics tools company enabling the discovery and use of protein biomarkers for the diagnosis and treatment of complex diseases. Aushon BioSystems was acquired by Quanterix in 2018. Prior to joining Aushon, she led the turnaround of SeraCare Life Sciences as President and CEO. There she successfully re-listed the company on NASDAQ and returned the company to profitability. Prior to that, Ms. Vogt held numerous senior level positions at Millipore Corporation, including Corporate Officer and President of the BioPharmaceutical Division.

Ms. Vogt has served on the board of directors and advisory boards of a number of other private and publicly held companies, including UK-based TAP BioSystems, and Belfast-based Andor Technologies, and currently serves on the Board of Anika Therapeutics (NASDAQ:ANIK) and Sharps Compliance (NASDAQ:SMED). Ms. Vogt received her M.B.A. from Boston University and a B.A. degree from Brown University.